Entrez gene 3082

Manufactured by Sino Biological

Sourced in China

Entrez Gene 3082 is a gene that encodes the human protein PCNA. PCNA is a DNA clamp that acts as a processivity factor for DNA polymerase delta in eukaryotic cells, enhancing the polymerase's activity during DNA replication and repair.

Automatically generated - may contain errors

Lab products found in correlation

Crizotinib, by Selleck Chemicals (2 mentions) Ricolinostat, by Selleck Chemicals (1 mentions)

2 protocols using entrez gene 3082

Evaluation of Crizotinib, Ricolinostat, and Chidamide

Check if the same lab product or an alternative is used in the 5 most similar protocols

Crizotinib (CAS No. 877399-52-5) and ricolinostat (CAS No. 1316214-52-4) were purchased from Selleck Chemicals (Houston, TX, USA). Chidamide (CAS No. 743420-02-2) was kindly provided by Shenzhen Chipscreen Biosciences Ltd. (Shenzhen, China). Human hepatocyte growth factor (HGF; Entrez Gene 3082) was purchased from Sino Biological, Inc. (10463-HNAS, Beijing, China).

Ding N., You A., Tian W., Gu L, & Deng D. (2020). Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation. International Journal of Biological Sciences, 16(14), 2595-2611.

+ Open protocol

+ Expand

Crizotinib and Chidamide Combination Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Crizotinib (CAS No. 877399-52-5) was purchased from Selleck Chemicals (S1068; Houston, TX, USA). Chidamide (CAS No. 743420-02-2) was kindly provided by Shenzhen Chipscreen Biosciences Ltd. (Shenzhen, China). Human hepatocyte growth factor (HGF; Entrez Gene 3082) was purchased from Sino Biological, Inc. (10463-HNAS, Beijing, China).

Ding N., You A., Tian W., Gu L., & Deng D. (2020). Chidamide increases the sensitivity of non-small cell lung cancer to crizotinib by decreasing c-MET mRNA methylation.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!